Nathalie was Board Member at OMass Therapeutics, and Senior Vice President and Head of Multiple Sclerosis & Immunology Development Unit at Biogen. Nathalie Franchimont joined Syncona in 2022.
Nathalie Franchimont is currently
Create your alert
to follow the career of Nathalie Franchimont.
Nathalie Franchimont has a PhD in Biomedical Sciences from Université de Liège.
They have also studied at Université de Liège :
Find more alumni from Université de Liège
Do you need to know more about Nathalie Franchimont? More results.
Report an error
Update the org chart details of Nathalie Franchimont.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.